Kentucky 2025 Regular Session

Kentucky House Bill HB506

Introduced
2/13/25  
Refer
2/13/25  

Caption

AN ACT relating to chronic pain treatments.

Impact

The implementation of HB506 is expected to significantly influence state healthcare laws by mandating that health benefit plans include coverage for an array of chronic pain treatment options. This would effectively shift the focus toward more holistic and integrative approaches to pain management, aligning with contemporary views on treating chronic pain without relying solely on pharmaceuticals. Additionally, the bill seeks to incentivize practitioners to broaden their treatment strategies, thereby enriching the spectrum of care available to patients.

Summary

House Bill 506 relates to chronic pain treatments and aims to enhance the accessibility of various therapeutic options for individuals experiencing chronic pain. Under the proposed legislation, health benefit plans are required to cover up to twenty visits per event for chronic pain treatments provided by licensed professionals in specified fields such as acupuncture, chiropractic services, and physical therapy. The bill aims to give patients more freedom in choosing their treatment options and accessing alternative therapies prior to resorting to prescription medications, such as opioids, which can be more harmful and addictive.

Sentiment

Sentiment surrounding HB506 appears to be backed by advocacy for patients’ rights and holistic health practices. Supporters emphasize that the bill will provide necessary relief for individuals suffering from chronic pain and reduce dependency on opioid prescriptions—addressing a critical health crisis. However, opponents express concerns regarding the feasibility of implementation and the potential for increased healthcare costs. Some stakeholders may also argue that mandating additional coverage could overburden insurance systems without guaranteeing improved health outcomes.

Contention

Key points of contention include debates over the extent of coverage required under the bill and the implications for healthcare providers. Critics are worried about the additional administrative burden this may impose on insurance companies and healthcare providers wary of increased liabilities. Moreover, there are discussions about whether the defined list of licensed professionals adequately represents a comprehensive approach to chronic pain treatment or if it should include a broader range of specialties. These concerns highlight the ongoing conflict between expanding treatment access and ensuring the sustainability of health benefit plans.

Companion Bills

No companion bills found.

Similar Bills

TX HB2811

Relating to the prescribing of controlled substances and dangerous drugs for acute pain.

TX HB2117

Relating to the prescribing of controlled substances and dangerous drugs for acute pain.

TX HB2995

Relating to the prescribing of medical cannabis for medical use to certain veterans with combat-related injuries or medical conditions and the licensing of dispensing organizations under the Texas Compassionate Use Program.

HI SB708

Relating To Prescriptive Authority For Clinical Psychologists.

TX SB2416

Relating to the medical use of low-THC cannabis and medical research cannabis.

SC S0161

Non-Opioid Pain Management

KY SB132

AN ACT relating to the recruitment and retention of health care professionals and declaring an emergency.

TX HB4045

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by patients with certain eligible medical conditions and the licensing of dispensing organizations; changing a fee.